People

Services

Industries

Firm

About

Knowledge

Careers

News

Events

Contact

Connect

Privacy Policy

Disclaimer

Terms of Use

Accessibility

Legal

Calgary

Toronto

Edmonton

Ottawa

Vancouver

New York

Montréal

Matt Riskin

Commercial Litigation, Health and Employment Lawyer at Bennett Jones Edmonton

Partner

Amy Verhoeff

Corporate Lawyer at Bennett Jones Edmonton

Associate

Jesse Fontaine

Commercial Transactions Lawyer at Bennett Jones Edmonton

On June 7, 2022, the Government of Alberta published Order in Council 200/2022, under which the Lieutenant Governor in Council ordered that the Financial Innovation Act, SA 2022 c F-13 be proclaimed into force on July 1, 2022. The same day, the Government of Alberta also published Order in Council 203/2022, establishing the Financial Innovation Regulation, Alta Reg 109/2022. The Regulations come into force simultaneously with the FIA.

The Financial Innovation Act Regulations and Coming Into Force July 1 2022

The Financial Innovation Act: Regulations and Coming Into Force July 1, 2022

On April 29, 2022, Bill 13 received royal assent, establishing the Financial Innovation Act, SA 2022 c F-13 (FIA). Bill 13 comes into force on proclamation. The regulations contemplated by Bill 13 have not been made publicly available at this time and additional requirements may be contained in such regulations. The exact scope of the FIA will be better known and understood once the regulations have been published.

Bill 13 the Financial Innovation Act An Opportunity to play in the Sandbox

Bill 13: the Financial Innovation Act: An Opportunity to play in the Sandbox

James J. Heelan KC

Commercial/Securities Litigation, Employment and Professional Negligence Lawyer and Mediator at Bennett Jones Edmonton

James Heelan and Amy Deprato write in Alberta Heavy on Bill 37 and Alberta's new payment and lien requirements in the construction industry.

Bill 37 New Year New Payment and Lien Requirements

Bill 37: New Year, New Payment and Lien Requirements in the Alberta Construction Industry

Kwang Lim

Corporate and Securities Lawyer at Bennett Jones Vancouver

Vancouver Managing Partner

Angela Blake

M&A, Securities and Corporate Finance Lawyer at Bennett Jones Toronto

Laura James

Corporate Lawyer at Bennett Jones Vancouver

M&amp;A activity in Canada rebounded in Q3 2025, with total deal value rising sharply year-over-year. Our update explores shifting deal structures, the rise of earnouts, cross-border dynamics, and the sectors driving growth.

Canadas Q3 2025 MA Landscape

Canada's Q3 2025 M&A Landscape

Lorelei Graham

Food and Agribusiness Lawyer, IP Lawyer, Litigation Lawyer at Bennett Jones Toronto

Dominique Carli

Commercial Transactions Lawyer at Bennett Jones Toronto

Wittington Investments has launched a C$100 million fund to support Canadian food producers with equity or debt financing. Success depends on legal readiness, from IP protection to governance, ensuring businesses are prepared to attract and secure investment.

Legal Readiness for Food Producers Navigating Wittington Investments C100M Fund

Legal Readiness for Food Producers: Navigating Wittington Investments’ C$100M Fund

Kees de Ridder

Intellectual Property Lawyer, Patent Agent and Trademark Agent at Bennett Jones Calgary

Associate, Patent Agent, Trademark Agent

Benjamin K. Reingold

Intellectual Property Litigation Lawyer at Bennett Jones Calgary

Stephen D. Burns

Technology Lawyer, Intellectual Property Lawyer at Bennett Jones Calgary

Partner, Trademark Agent

The Supreme Court of Canada will hear Pharmascience Inc v Janssen Inc on October 9, 2025, a case that could reshape the scope of patentable subject matter in Canada. At issue is whether a dosing regimen for a pharmaceutical product constitutes an unpatentable method of medical treatment or a valid invention under the Patent Act. The Federal Court and Federal Court of Appeal upheld the patent&rsquo;s validity, but Pharmascience has challenged this position. With several industry groups granted intervenor status, the case is expected to have significant implications not only for the pharmaceutical industry but also for broader questions of what qualifies as an &ldquo;invention,&rdquo; including computer-implemented and AI-related technologies.

Supreme Court to Assess Subject Matter Eligibility in Canadian

Supreme Court to Assess Subject Matter Eligibility in Canadian Patent Law: Implications Beyond the Pharmaceutical Context

AI is transforming performance marketing through hyper-personalization, automated content creation, and data-driven insights&mdash;enhancing efficiency while raising new legal and ethical considerations for brands.

The Implications of AI on Performance Marketing

Sean Zweig

Restructuring, Insolvency and Bankruptcy Lawyer at Bennett Jones Toronto

Andrew Froh

Commercial Litigation Lawyer at Bennett Jones Vancouver

James Atkinson

Articling Student at Bennett Jones 

Articling Student          

A recent decision of the US Bankruptcy Court in Re: Iovate Health Sciences International Inc. provides important insights for Canadian companies involved in cross-border restructurings. The case addresses how debtor companies can rebut the presumption that their &ldquo;center of main interests&rdquo; (COMI) is located at their registered office when seeking Chapter 15 recognition in the United States. Chief Judge Glenn reaffirmed that COMI is determined by a non-exhaustive set of factors, including management, assets, creditors and creditor expectations, and may also be influenced by pre-filing restructuring activities.

Oppression Claims and Derivative Actions

From the Same Authors